Westfield Capital Management
XENT

Westfield Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Westfield Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-456,423
Closed -$5.41M – 258
2020
Q1 		$5.41M Sell
456,423
-671,242
-60% -$14.9M 0.05% 193
2019
Q4 		$28.1M Sell
1,127,665
-69,261
-6% -$1.4M 0.2% 138
2019
Q3 		$20.4M Sell
1,196,926
-17,099
-1% -$311K 0.16% 156
2019
Q2 		$27.6M Buy
1,214,025
+561,244
+86% +$15.1M 0.21% 146
2019
Q1 		$21M Sell
652,781
-33,075
-5% -$1.02M 0.16% 171
2018
Q4 		$19.3M Buy
685,856
+211,574
+45% +$6.2M 0.16% 165
2018
Q3 		$13.6M Buy
474,282
+12,750
+3% +$383K 0.1% 190
2018
Q2 		$17.3M Buy
+461,532
New +$18.1M 0.13% 191

Other funds holding XENT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Westfield Capital Management's XENT Position: Q2 2020 in Review

Westfield Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2020, closing a stake of 456,423 shares — an estimated $5.41M sold.

Westfield Capital Management first reported a position in XENT in Q2 2018 and held it in 8 quarters. The position peaked at $28.1M in Q4 2019. 108 funds tracked by Wall St. Rank hold XENT as of Q2 2020.

  • Westfield Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2020 after selling out during the quarter.
  • Westfield Capital Management sold 456,423 Intersect ENT, Inc shares in Q2 2020, an estimated $5.41M.
  • Westfield Capital Management first reported a position in Intersect ENT, Inc in Q2 2018 and held it in 8 quarters.
  • Westfield Capital Management's Intersect ENT, Inc position peaked at $28.1M in Q4 2019.
  • 108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2020.

Based on Westfield Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.